|
Market Closed -
Toronto S.E.
23:59:34 19/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 9.180 CAD | -0.76% |
|
-7.27% | +15.91% |
| 10-05 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 10-05 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SATELLOS BIOSCIENCE INC. | Bio Therapeutic Drugs | -0.76% | -7.27% | +15.91% | -3.16% | -47.60% | 139M |  |  | |
- Stock Market
- Stocks
- MSCL Stock
- Charts Satellos Bioscience Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
